GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **301 - 325** of **4050** in total

« First

‹ Prev

…

9

10

11

12

13

14

15

16

17

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgA	Patient 1	10	moderate	G02670IJ	386
IgA	Patient 1	22	moderate	G02670IJ	369
IgA	Patient 1	6	moderate	G02670IJ	322
IgG	Patient 1	10	moderate	G02670IJ	25
IgG	Patient 1	22	moderate	G02670IJ	28
IgG	Patient 1	6	moderate	G02670IJ	24
IgM	Patient 1	10	moderate	G02670IJ	55
IgM	Patient 1	22	moderate	G02670IJ	117
IgM	Patient 1	6	moderate	G02670IJ	43
IgA	Patient 2	15	mild	G02670IJ	318
IgA	Patient 2	24	mild	G02670IJ	392
IgG	Patient 2	15	mild	G02670IJ	32
IgG	Patient 2	24	mild	G02670IJ	35
IgM	Patient 2	15	mild	G02670IJ	138
IgM	Patient 2	24	mild	G02670IJ	178
IgA	Patient 2	3	mild	G02670IJ	371
IgG	Patient 2	3	mild	G02670IJ	38
IgM	Patient 2	3	mild	G02670IJ	201
IgA	Patient 3	-180	mild	G02670IJ	281
IgA	Patient 3	11	mild	G02670IJ	424
IgG	Patient 3	-180	mild	G02670IJ	44
IgG	Patient 3	11	mild	G02670IJ	51
IgM	Patient 3	-180	mild	G02670IJ	139
IgA	Patient 3	4	mild	G02670IJ	442
IgG	Patient 3	4	mild	G02670IJ	47